Home > Neurology > AAN 2022 > Epilepsy > Laser interstitial thermal therapy for refractory epilepsy

Laser interstitial thermal therapy for refractory epilepsy

Presented By
Prof. Varun Kumar, Icahn School of Medicine at Mount Sinai, NY, USA
Conference
AAN 2022
Doi
https://doi.org/10.55788/b3e2ffc3
In 2 presentations at the AAN 2022, laser interstitial thermal therapy (LITT) was evaluated as an upcoming, minimally-invasive treatment option for refractory epilepsy. LITT was found to be safe in carefully selected patients. Careful management of post-operative seizures and discharge planning after epilepsy surgery may be important to optimise outcomes and reduce the risk of readmission. A first study reported the trends and outcomes in the USA after surgical procedures for refractory epilepsy [1]. LITT has the advantage of being minimally invasive and is increasingly used for different brain lesions, offering seizure outcomes comparable with those of more traditional open surgery. In order to compare LITT to other procedures, all adult refractory epilepsy patients in the Nationwide Readmission Database were included who had either open surgery or LITT and were then readmitted within a month after discharge between 2012 and 2018. Of 205,...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on